Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Journal of Clinical Psychopharmacology
|
May 6, 2008
Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia
John M Kane, John Lauriello, Eugene Laska, et al.
Journal of Community Health
|
May 24, 2015
Outcomes of The BODY Project: A Program to Halt Obesity and Its Medical Consequences in High School Students
Victoria Sweat, Jean-Marie Bruzzese, Arthur Fierman, et al.
General Hospital Psychiatry
|
March 10, 2017
Making the cut: Depression screening in urban general hospital clinics for culturally diverse Latino populations
Damara Gutnick, Carole Siegel, Eugene Laska, et al.
Addiction (Abingdon, England)
|
February 24, 2015
Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial
Joshua D Lee, Ryan McDonald, Ellie Grossman, et al.
Substance Use & Addiction Journal
|
May 5, 2025
Identifying Alcohol Use Disorder and Problem Use in Adult Primary Care Patients: Comparison of the Tobacco, Alcohol, Prescription Medication and Other Substance (TAPS) Tool With the Alcohol Use Disorders Identification Test Consumption Items (AUDIT-C)
Angéline Adam, Eugene Laska, Robert P Schwartz, et al.
Schizophrenia Research
|
February 4, 2014
d-Cycloserine augmentation of cognitive remediation in schizophrenia
Christopher K Cain, Margaret McCue, Iruma Bello, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 10, 2006
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial
Christopher G Goetz, Philippe Damier, Christine Hicking, et al.
Addiction Science & Clinical Practice
|
October 17, 2019
Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool
Angéline Adam, Robert P Schwartz, Li-Tzy Wu, et al.
Sleep
|
December 6, 2003
Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia
Andrew D Krystal, James K Walsh, Eugene Laska, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 5, 2008
Placebo influences on dyskinesia in Parkinson's disease
Christopher G Goetz, Eugene Laska, Christine Hicking, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Journal of Clinical Psychopharmacology
|
May 6, 2008
Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia
John M Kane, John Lauriello, Eugene Laska, et al.
Journal of Community Health
|
May 24, 2015
Outcomes of The BODY Project: A Program to Halt Obesity and Its Medical Consequences in High School Students
Victoria Sweat, Jean-Marie Bruzzese, Arthur Fierman, et al.
General Hospital Psychiatry
|
March 10, 2017
Making the cut: Depression screening in urban general hospital clinics for culturally diverse Latino populations
Damara Gutnick, Carole Siegel, Eugene Laska, et al.
Addiction (Abingdon, England)
|
February 24, 2015
Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial
Joshua D Lee, Ryan McDonald, Ellie Grossman, et al.
Substance Use & Addiction Journal
|
May 5, 2025
Identifying Alcohol Use Disorder and Problem Use in Adult Primary Care Patients: Comparison of the Tobacco, Alcohol, Prescription Medication and Other Substance (TAPS) Tool With the Alcohol Use Disorders Identification Test Consumption Items (AUDIT-C)
Angéline Adam, Eugene Laska, Robert P Schwartz, et al.
Schizophrenia Research
|
February 4, 2014
d-Cycloserine augmentation of cognitive remediation in schizophrenia
Christopher K Cain, Margaret McCue, Iruma Bello, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 10, 2006
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial
Christopher G Goetz, Philippe Damier, Christine Hicking, et al.
Addiction Science & Clinical Practice
|
October 17, 2019
Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool
Angéline Adam, Robert P Schwartz, Li-Tzy Wu, et al.
Sleep
|
December 6, 2003
Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia
Andrew D Krystal, James K Walsh, Eugene Laska, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 5, 2008
Placebo influences on dyskinesia in Parkinson's disease
Christopher G Goetz, Eugene Laska, Christine Hicking, et al.
Page
of 5